New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients experiencing facial volume loss following medication-driven weight loss, according to ...
A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...
President-elect Donald Trump faces deep skepticism that his administration's policies will make health care more affordable, ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
GLP-1 drugs like Ozempic became so popular as weight loss drugs that there was a mid-year shortage. These drugs are also ...
Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss. GLP-1 medications were originally intended to ...
Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...
But now that these drugs are in greater demand from both patients and doctors, state Medicaid programs are grappling with whether to cover them for weight loss, both for reasons of equity and to save ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...
While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback